Skip to main content

Showing results for CTSI

Statewide institute receives $38M NIH grant to advance health research in Indiana

The Indiana Clinical and Translational Sciences Institute (CTSI) has secured nearly $38 million in renewed funding from the National Institutes of Health for the next seven years — the fourth consecutive successful grant submission for the statewide research enterprise.

Indiana Clinical and Translational Sciences Institute  |  Mar 20, 2023

Cold Spring Harbor Laboratory researcher named 2022 Watanabe Prize winner

Adrian Krainer, PhD is this year’s winner of the August M. Watanabe Prize in Translational Research and will be honored at the 2022 Indiana Clinical and Translational Sciences (CTSI) Annual Meeting on Friday, September 16. Krainer is currently the St. Giles Foundation Professor at Cold Spring Harbor Laboratory in New York. 

IU School of Medicine  |  Jun 16, 2022

Statewide study shows COVID-19 antibodies last longer in children than adults, but diminish over time

Indiana University School of Medicine researchers are sharing the results of a study about how immunity to COVID-19 can develop and change over time.

IU School of Medicine  |  Apr 28, 2022

IU School of Medicine researchers draw analogies between art and science in new study

Indiana University School of Medicine researchers have discovered an innovative approach to identifying how likely someone is to develop certain diseases.

IU School of Medicine  |  Feb 08, 2022

IU exceeds several underrepresented population recruitment goals in COVID-19 vaccine study

Indiana University School of Medicine announced that of the thousands of participants who enrolled across the United States in the late stage clinical study of an investigational COVID-19, 530 Indiana residents participated in the study at the IU School of Medicine site.

IU School of Medicine  |  Mar 30, 2021

Findings from asymptomatic COVID-19 study in Marion County contain important information for parents, their children

A study conducted by Indiana University School of Medicine researchers has shown that asymptomatic COVID-19 infection is possible in children younger than 10 years old. The researchers have shared the results of their novel COVID-19 study of asymptomatic children and adults in Marion County known as TACTIC (Tracking Asymptomatic COVID-19 Through Indianapolis Communities). 

IU School of Medicine  |  Aug 26, 2020

IU School of Medicine announces multi-million dollar strategic research agreement with Lilly

Indiana University School of Medicine announced today a strategic research agreement with Eli Lilly and Company designed to ultimately benefit people suffering from a variety of autoimmune diseases. The five-year, five-million-dollar deal will span multiple projects and teams. The purpose of the agreement is to gain an understanding of the molecular and cellular changes which occur in patients after administration of some of Lilly’s currently marketed autoimmune therapies that are also being developed for the potential of new autoimmune diseases, including inflammatory bowel disease and psoriasis.

IU School of Medicine  |  Jul 21, 2020

2 physician-scientists to lead Indiana Clinical and Translational Sciences Institute

INDIANAPOLIS — The Indiana Clinical and Translational Sciences Institute (CTSI) announced today that Sharon M. Moe, MD and Sarah E. Wiehe, MD, MPH have assumed the roles of co-leaders of the institute that is focused on improving health in Indiana through a research partnership among the state’s leading research universities of Indiana University (IU), Purdue University and the University of Notre Dame.

IU School of Medicine  |  Jun 16, 2020

Researchers grow hairy skin from human stem cells

Building on years of groundbreaking discoveries in stem cell research, scientists from Indiana University School of Medicine and Harvard Medical School have determined how to grow hairy skin using human stem cells—developing one of the most complex skin models in the world. The study, published June 3 in Nature, shows that skin generated from pluripotent stem cells can be successfully grafted on a nude mouse to grow human skin and hair follicles. That discovery could lead to future studies in skin reconstruction, disease modeling and treatment.

IU School of Medicine  |  Jun 04, 2020

IU School of Medicine researchers predict which triple negative breast cancer patients may avoid recurrence and those who are at high-risk of relapse

SAN ANTONIO — Indiana University School of Medicine researchers have discovered how to predict whether triple negative breast cancer will recur, and which women are likely to remain disease-free. They will present their findings on December 13, 2019, at the San Antonio Breast Cancer Symposium, the most influential gathering of breast cancer researchers and physicians in the world.   Milan Radovich, PhD, and Bryan Schneider, […]

IU School of Medicine  |  Dec 13, 2019